COVID-19 vaccinology landscape in Africa

dc.contributor.authorBaptista, Sara
dc.contributor.authorNaidoo, Sanushka
dc.contributor.authorSuliman, Sara
dc.contributor.authorNepolo, Emmanuel
dc.contributor.authorKanoi, Bernard N.
dc.contributor.authorGitaka, Jesse
dc.contributor.authorBlessing, Oyedemi Mbaebie
dc.contributor.authorEnany, Shymaa
dc.date.accessioned2023-07-05T05:06:58Z
dc.date.available2023-07-05T05:06:58Z
dc.date.issued2022-12-05
dc.description.abstractMore than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa.en_US
dc.description.departmentBiochemistryen_US
dc.description.departmentForestry and Agricultural Biotechnology Institute (FABI)en_US
dc.description.departmentGeneticsen_US
dc.description.departmentMicrobiology and Plant Pathologyen_US
dc.description.librarianam2023en_US
dc.description.sponsorshipThe Massachusetts Life Sciences Center Accelerating Coronavirus Testing Solutions, Nina Ireland Program for Lung Health, the Chan Zuckerberg Biohub Initiative and Africa Academy of Sciences funding for COVID-19 Research & Development goals for Africa.en_US
dc.description.urihttps://www.frontiersin.org/journals/immunologyen_US
dc.identifier.citationBaptista, S., Naidoo, S., Suliman, S., Nepolo, E., Kanoi, B.N., Gitaka, J., Blessing, O.M. & Enany, S. (2022) COVID-19 vaccinology landscape in Africa. Frontiers in Immunology 13:955168. DOI: 10.3389/fimmu.2022.955168.en_US
dc.identifier.issn1664-3224 (online)
dc.identifier.other10.3389/fimmu.2022.955168
dc.identifier.urihttp://hdl.handle.net/2263/91264
dc.language.isoenen_US
dc.publisherFrontiers Mediaen_US
dc.rights© 2022 Baptista, Naidoo, Suliman, Nepolo, Kanoi, Gitaka, Blessing and Enany. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).en_US
dc.subjectVaccinologyen_US
dc.subjectAfricaen_US
dc.subjectLocal manufactureen_US
dc.subjectImproved accessen_US
dc.subjectVaccinesen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleCOVID-19 vaccinology landscape in Africaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Baptista_COVID19_2022.pdf
Size:
2.88 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: